The Biotech Growth Trust PLC (LON:BIOG - Get Free Report) shares shot up 2.1% during mid-day trading on Thursday . The stock traded as high as GBX 786 ($10.68) and last traded at GBX 780 ($10.60). 46,151 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 156,838 shares. The stock had previously closed at GBX 764 ($10.38).
The Biotech Growth Trust Trading Up 2.1%
The company has a market cap of £222.84 million, a P/E ratio of 2.62 and a beta of 0.50. The company has a quick ratio of 0.00, a current ratio of 0.59 and a debt-to-equity ratio of 11.02. The business has a 50-day moving average price of GBX 731.59 and a two-hundred day moving average price of GBX 774.12.
Insiders Place Their Bets
In related news, insider Roger Yates acquired 10,000 shares of the firm's stock in a transaction that occurred on Wednesday, June 4th. The stock was acquired at an average cost of GBX 747 ($10.15) per share, with a total value of £74,700 ($101,480.78). Also, insider Nicola Shepherd acquired 500 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The shares were bought at an average cost of GBX 771 ($10.47) per share, with a total value of £3,855 ($5,237.06). Insiders own 0.71% of the company's stock.
The Biotech Growth Trust Company Profile
(
Get Free Report)
The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider The Biotech Growth Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Biotech Growth Trust wasn't on the list.
While The Biotech Growth Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
